SMTI

32.5500.37%
EB

Elizabeth B. Taylor

Chief Financial Officer

Ms. Elizabeth B. Taylor is Chief Financial Officer of Sanara MedTech Inc. from January 15, 2025. Ms. Taylor was CEO & Director of Imbed Biosciences, Inc. She possesses financial experience, with a career history that includes prior positions as Chief Financial Officer of a medical device company focused on the treatment of wounds, Chief Operating Officer of multiple hedge funds and as a member of the investment team at a leading private equity firm. Her combination of industry and Wall Street experience complements the strengths of existing finance and accounting teams. Ms. Taylor joins Sanara from Imbed Biosciences. She served as its Chief Financial Officer from 2023 to 2025, where she was responsible for budgeting, forecasting and financial analysis and as a member of its board of directors from 2018 to 2023. Beginning in 2011, Ms. Taylor previously worked as an umbrella financial advisor for family offices and high-net worth clients at Burnett Taylor Consulting, LLC, which she founded and managed. From 2008 to 2010, Ms. Taylor served as Chief Operating Officer of PioneerPath Capital, an alternative asset manager and incubation platform within Citadel, a global investment firm. Ms. Taylor was responsible for the platform's launch and business management, including overseeing all internal accounting, budgeting and management reporting functions. She was Chief Operating Officer of Tala Investments, L.P., a value-focused hedge fund, from 2005 to 2008. Prior to Tala Investments, Ms. Taylor worked for Thomas H. Lee Partners, L.P. (THL), a private equity firm focused on investing in middle-market growth companies, joining firm as an investment analyst for the firm's private equity fund. Ms. Taylor holds an M.B.A. from Harvard Business School and a B.A. from Princeton University.

Positions